Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Kardiologia Polska|November 14, 2017
Negative predictors of treatment success in outpatient therapy of arterial hypertension in Poland. Results of the CONTROL NT observational registryKrzysztof J Filipiak, Mariusz Tomaniak, Anna E Płatek, et al.Cardiology Journal|March 4, 2015
Can thromboembolic risk be associated with erectile dysfunction in atrial fibrillation patients?Filip M Szymański, Krzysztof J Filipiak, Anna E Płatek, et al.Acta Cardiologica|September 18, 2008
Usefulness of myocardial necrosis triad markers for predicting 4-year mortality in patients with suspected acute coronary syndromeFilip M Szymański, Marcin Grabowski, Anna Hrynkiewicz, et al.Kardiologia Polska|March 20, 2012
[Advanced programming of cardiac resynchronisation therapy under echocardiographic examination: is it feasible and efficient?]Alicja Dąbrowska Kugacka, Anna Faran, Ewa Lewicka, et al.Acta Cardiologica|January 12, 2010
Does time delay between the primary cardiac arrest and PCI affect outcome?Filip M Szymański, Marcin Grabowski, Grzegorz Karpiński, et al.Kardiologia Polska|March 28, 2014
Obstructive sleep apnoea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish populationFilip M Szymański, Anna E Płatek, Grzegorz Karpiński, et al.Kardiologia Polska|February 15, 2014
Sleep duration in the first months after ST elevation myocardial infarction: an independent predictor of all-cause mortalityFilip M Szymański, Krzysztof J Filipiak, Anna E Płatek, et al.Kardiologia Polska|January 4, 2018
Evaluation of the prevalence of periodontal disease as a non-classical risk factor in the group of patients undergoing hip and/or knee arthroplastyKarolina Adamkiewicz, Anna E Płatek, Paweł Łęgosz, et al.Kardiologia Polska|January 10, 2018
Utilisation of lipid-lowering therapies in outpatient settings in Poland: epidemiological survey Economedica Dyslipidaemia 2015Filip M Szymański, Anna E Płatek, Anna Ryś, et al.Advances in Therapy|November 30, 2021
Drug Interactions Affecting Kidney Function: Beware of Health Threats from Triple WhammyTomasz Harężlak, Urszula Religioni, Filip M Szymański, et al.Pageof 4